🔎 Trials Near Me

Akèy › Kansè nan tete › Kalifòni › Sacramento

Etid klinik pou Kansè nan tete nan Sacramento, CA

20 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Sacramento (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Ap rekriteFaz 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Ap rekriteFaz 3
  • Sutter Inst Medical Research, Sacramento
  • School Of Medicine, Sacramento
Laj 18 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Ap rekrite
  • Kaiser Permanente-South Sacramento, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Ap rekriteVolontè an sante akeyi
  • University of California Davis, Sacramento
Laj 30 a 74 · Fanm · Mizajou Sep 21, 2026 · NCT02620852

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Ap rekriteFaz 3
  • University Of California Davis Health System, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07173751

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Ap rekriteEtid obsèvasyon
  • UC Davis, Sacramento
Laj 18 a 94 · Fanm · Mizajou Sep 17, 2026 · NCT07505797

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Ap rekriteFaz 3
  • Dignity Health dba Health Research Institute, Sacramento
  • Sutter Institute for Medical Research, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06492616

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • ak 5 plis
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

Ap rekriteVolontè an sante akeyi
  • University of California, Davis, Sacramento
Laj 25 ak plis · Fanm · Mizajou Sep 1, 2026 · NCT03729115

E-Mindfulness Approaches for Living After Breast Cancer

Ap rekriteFaz 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

Ap rekrite
  • University of California, Davis, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT06103669

UHFUS Characterization of Normal Lymphatic Anatomy

Ap rekrite
  • University of California Davis Health, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT07677839

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Ap rekriteFaz 2
  • University of California - Davis, Comprehensive Cancer Center, Davis · 14 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT01042379

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Sutter Medical Center Sacramento, Sacramento
  • ak 4 plis
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Apr 6, 2026 · NCT05785741

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Ap rekriteFaz 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT06268665

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Ap rekriteFaz 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06778863

Etid Kansè nan tete nan lòt vil

Lòt etid nan Sacramento

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.